Larimar Therapeutics Inc (LRMR)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -36.092 | -43.881 | -54.004 | -44.846 | -45.822 | -55.233 | -34.481 | -33.236 |
Return on Equity (%) | -39.801 | -52.043 | -71.571 | -61.821 | -59.284 | -65.716 | -40.333 | -38.364 |
Return on Invested Capital (%) | -39.591 | -48.219 | -59.181 | -53.988 | -57.585 | -67.135 | -42.638 | -44.271 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 4.453 | 2.845 | 2.501 | 1.432 | 5.836 | 3.637 | 2.563 | 1.861 |
Earnings Per Share | -2.118 | -1.893 | -1.646 | -1.213 | -2.764 | -2.859 | -0.817 | -0.842 |
Cash Per Share | 1.184 | 1.483 | 1.323 | 0.727 | 4.434 | 3.958 | 0.62 | 0.609 |
Working Capital Per Share | 4.427 | 3.552 | 2.897 | 1.584 | 5.789 | 3.578 | 2.543 | 1.837 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.118 | -1.893 | -1.646 | -1.213 | -2.764 | -2.859 | -0.817 | -0.842 |
EBITDA Per Share | -2.118 | -1.893 | -1.646 | -1.213 | -2.764 | -2.859 | -0.817 | -0.842 |
Free Cash Flow Per Share | -2.101 | -1.898 | -1.65 | -1.199 | -2.77 | -2.852 | -0.819 | -0.845 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 27.33M | 27.49M | 37.29M | 37.45M | 15.37M | 17.71M | 43.27M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 43.27M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 393.05M |
Price to Earnings Ratio | -1.71 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.36 |
Price to Book Ratio | 0.77 |
Dividend Yield | - |
Shares Outstanding | 63.81M |
Average Volume (1 week) | 808.53k |
Average Volume (1 Month) | 780.06k |
52 Week Change | 76.90% |
52 Week High | 13.68 |
52 Week Low | 3.0499 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.